NDC properties for "lenalidomide 20 MG Oral Capsule" (RxCUI 1428947)
About this data
The tables show NDC propoerties for lenalidomide 20 MG Oral Capsule with the RxCUI 1428947
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for lenalidomide 20 MG Oral Capsule (RxCUI 1428947)
| ANDA | ANDA201452 |
|---|---|
| ANDA | ANDA209348 |
| ANDA | ANDA210154 |
| ANDA | ANDA210435 |
| ANDA | ANDA210480 |
| ANDA | ANDA211022 |
| ANDA | ANDA211846 |
| ANDA | ANDA212414 |
| ANDA | ANDA213885 |
| ANDA | ANDA213912 |
| MMSL_CODE | BD28686 |
| MMSL_CODE | CD28686 |
| RxCUI | 1428947 |
| SNOMEDCT | 840660008 |
| SPL_SET_ID | 51bfdd53-8fd9-4f86-bebe-75de29e6379d |
| SPL_SET_ID | 682e8a86-9f49-45db-a2ea-403ee1dc62d2 |
| SPL_SET_ID | 76f6c1e7-985b-43d9-892c-849df50ae80e |
| SPL_SET_ID | 84d9dec7-9250-4dbd-9a0d-23e75f111892 |
| SPL_SET_ID | 9943e098-20b0-dbb3-af12-7816eedd3f70 |
| SPL_SET_ID | 9d401422-072b-4b69-aeef-da1f9534c3ec |
| SPL_SET_ID | adee5af1-c9ab-c0c7-e400-dea7d2a0d4be |
| SPL_SET_ID | ba2a07fd-ca60-40bc-b79b-9caf81900fa3 |
| SPL_SET_ID | c98fb504-76d0-4c25-9c0b-412885828a7a |
| SPL_SET_ID | ca8cc2cc-c856-e676-4f60-1e46d7b53d73 |
| SPL_SET_ID | f27092f3-3977-4f4a-b214-45309e136e46 |
| SPL_SET_ID | fd23328f-b019-4c14-80d9-4ebd997f26b2 |
| VUID | 4032493 |
| Prescribable Synonym | lenalidomide 20 MG Oral Capsule |
| RXNAV_STR | lenalidomide 20 MG Oral Capsule |
| RxNorm Name | lenalidomide 20 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 1428947) |
NDC Properties
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |
NDC Item 00378194201
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-01 |
| NDC Item | 00378194201 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-01) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00378194221
| NDC 9 | 0378-1942 |
|---|---|
| NDC 10 | 0378-1942-21 |
| NDC Item | 00378194221 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1942-21) |
| ANDA | ANDA213912 |
| COLORTEXT | GREEN(green opaque),WHITE(white opaque) |
| Color | C48329;C48325 __ |
| FDA SPL set id | 745620 |
| Imprint code | MYLAN;LL;20 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1942 |
NDC Item 00480124521
| NDC 9 | 0480-1245 |
|---|---|
| NDC 10 | 0480-1245-21 |
| NDC Item | 00480124521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1245-21) |
| ANDA | ANDA201452 |
| COLORTEXT | green,blue |
| Color | C48329;C48333 __ |
| FDA SPL set id | 782674 |
| Imprint code | NAT;20mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-08 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1245 |
NDC Item 31722026101
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-01 |
| NDC Item | 31722026101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-261-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 31722026121
| NDC 9 | 31722-261 |
|---|---|
| NDC 10 | 31722-261-21 |
| NDC Item | 31722026121 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-261-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white,brown |
| Color | C48325;C48332 __ |
| FDA SPL set id | 802288 |
| Imprint code | H;L6 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-261 |
NDC Item 43598051401
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-01 |
| NDC Item | 43598051401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-514-01) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 43598051421
| NDC 9 | 43598-514 |
|---|---|
| NDC 10 | 43598-514-21 |
| NDC Item | 43598051421 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-514-21) |
| ANDA | ANDA209348 |
| COLORTEXT | YELLOW(yellow opaque colored cap),BLUE(blue opaque colored body) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 727151 |
| Imprint code | RDY;20;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-514 |
NDC Item 47781048701
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-01 |
| NDC Item | 47781048701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-487-01) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 47781048777
| NDC 9 | 47781-487 |
|---|---|
| NDC 10 | 47781-487-77 |
| NDC Item | 47781048777 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-487-77) |
| ANDA | ANDA210480 |
| COLORTEXT | RED(warm brick red),GRAY(light gray) |
| Color | C48326;C48324 __ |
| FDA SPL set id | 789803 |
| Imprint code | LP;641 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 47781-487 |
NDC Item 59651034601
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-01 |
| NDC Item | 59651034601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-346-01) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034607
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-07 |
| NDC Item | 59651034607 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-346-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 59651034621
| NDC 9 | 59651-346 |
|---|---|
| NDC 10 | 59651-346-21 |
| NDC Item | 59651034621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-346-21) |
| ANDA | ANDA213885 |
| COLORTEXT | ORANGE(Orange Opaque Cap, Orange Opaque Body) |
| Color | C48331 __ |
| FDA SPL set id | 717399 |
| Imprint code | L;20 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-346 |
NDC Item 60505453602
| NDC 9 | 60505-4536 |
|---|---|
| NDC 10 | 60505-4536-2 |
| NDC Item | 60505453602 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4536-2) |
| ANDA | ANDA211022 |
| COLORTEXT | BLUE(powder blue opaque),BLUE(Blue green opaque) |
| Color | C48333;C48333 __ |
| FDA SPL set id | 794910 |
| Imprint code | APO;L20 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-09 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 14 mm |
| Related queries | Properties for NDC 9 60505-4536 |
NDC Item 63304004501
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-01 |
| NDC Item | 63304004501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-045-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 63304004522
| NDC 9 | 63304-045 |
|---|---|
| NDC 10 | 63304-045-22 |
| NDC Item | 63304004522 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-045-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| FDA SPL set id | 701728 |
| Imprint code | RL;;82 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-045 |
NDC Item 69097038481
| NDC 9 | 69097-384 |
|---|---|
| NDC 10 | 69097-384-81 |
| NDC Item | 69097038481 |
| Packaging | 21 CAPSULE in 1 BOTTLE (69097-384-81) |
| ANDA | ANDA210435 |
| COLORTEXT | BLUE(blue green and pale blue) |
| Color | C48333 __ |
| FDA SPL set id | 698711 |
| Imprint code | cipla20mg;384 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-384 |
NDC Item 70710103401
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-1 |
| NDC Item | 70710103401 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1034-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70710103408
| NDC 9 | 70710-1034 |
|---|---|
| NDC 10 | 70710-1034-8 |
| NDC Item | 70710103408 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1034-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 770365 |
| Imprint code | 1034 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70710-1034 |
NDC Item 70771168001
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-1 |
| NDC Item | 70771168001 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1680-1) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 70771168008
| NDC 9 | 70771-1680 |
|---|---|
| NDC 10 | 70771-1680-8 |
| NDC Item | 70771168008 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1680-8) |
| ANDA | ANDA210154 |
| COLORTEXT | BLUE(light blue opaque cap turquoise blue opaque body) |
| Color | C48333 __ |
| FDA SPL set id | 800438 |
| Imprint code | 1034 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 19 mm |
| Related queries | Properties for NDC 9 70771-1680 |
NDC Item 76282070047
| NDC 9 | 76282-700 |
|---|---|
| NDC 10 | 76282-700-47 |
| NDC Item | 76282070047 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-700-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE(Blue green and Pale blue) |
| Color | C48325 __ |
| FDA SPL set id | 792852 |
| Imprint code | Cipla20mg;384 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-06-10 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-700 |